rs587783766
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_000252.3(MTM1):c.1244G>A(p.Gly415Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000252.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MTM1 | NM_000252.3 | c.1244G>A | p.Gly415Glu | missense_variant | Exon 11 of 15 | ENST00000370396.7 | NP_000243.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Severe X-linked myotubular myopathy Pathogenic:2
- -
Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Likely pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with X-linked centronuclear myopathy (MIM#310400). (I) 0109 - This gene is associated with X-linked recessive disease; however, manifesting female carriers of pathogenic variants who present with a range of clinical severity and skewed X-inactivation are increasingly being reported (GeneReviews, PMID: 28685322). (I) 0115 - Variants in this gene are known to have variable expressivity. Female carriers of pathogenic variants have been reported with a range of clinical severity, ranging from severe neonatal and generalized weakness, to milder adult forms (PMID: 28685322). (I) 0200 - Variant is predicted to result in a missense amino acid change from glycine to glutamic acid. (I) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools and highly conserved with a major amino acid change. (SP) 0600 - Variant is located in the annotated myotubularin-like phosphatase domain (DECIPHER). (I) 0704 – Another missense variant comparable to the one identified in this case has limited previous evidence for pathogenicity. The p.(Gly415Val) variant has been identified in one individual with severe myotubular myopathy (PMID: 15725586). (SP) 0803 - This variant has limited previous evidence of pathogenicity in unrelated individuals. This variant has been classified once as likely pathogenic and once as pathogenic by clinical diagnostic laboratories (ClinVar). (SP) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -
not provided Pathogenic:1
Has been reported previously as pathogenic/likely pathogenic variant in association with myotubular myopathy, however, additional information was not provided (Penon et al., 2018); Different missense variant at the same residue, G415V, was identified in a patient with a severe MTM1-related disorder, however, specific clinical and family segregation information was not included (Tsai et al., 2005); This variant is associated with the following publications: (PMID: 30047259) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at